PRSVX
TRPrice SmallCap Value-Inv
Targeting Undervalued Small-Cap Stocks
The TRPrice SmallCap Value-Inv fund, with ticker symbol PRSVX, is designed to capture long-term capital growth by investing primarily in small-cap companies that are undervalued yet have promising prospects for capital appreciation. This fund is part of the T. Rowe Price family and is directly sold, making it accessible to a wide range of investors. The fund’s strategy focuses on identifying companies with small market capitalizations that are believed to be trading below their intrinsic value. This approach aims to capitalize on the potential for these companies to grow and increase in value over time, offering investors the opportunity to benefit from significant capital gains.
At A Glance
Executive Summary
PRSVX offers a unique focus on undervalued small-cap stocks with a competitive 0.8% expense ratio, aiming for long-term growth.
Focus on undervalued small-cap stocks Competitive expense ratio Strong 1-year return of 36.69%
Higher risk with small-cap focus Negative alpha and Sharpe ratio Limited bond diversification
Performance Amidst Market Volatility
PRSVX has demonstrated a strong performance over the past year, with a notable 1-year return of 36.69%, which is competitive when compared to its benchmark, the S&P 500 Total Return Index, which posted a 37.62% return. Despite the fund’s impressive short-term performance, it is important to note the volatility associated with small-cap investments. The fund’s beta of 1.14 indicates a higher sensitivity to market movements compared to the benchmark, suggesting that while the fund can outperform in bullish markets, it may also experience greater losses during downturns. Investors should consider this volatility when evaluating the fund’s suitability for their portfolio.
Sector and Asset Allocation Insights
The fund’s portfolio is heavily weighted towards the financial sector, which constitutes 26.42% of its holdings, followed by real estate and industrials at 12.74% and 12.55%, respectively. This sector allocation reflects the fund’s strategy of investing in undervalued small-cap companies, many of which are found in these sectors. Additionally, the fund maintains a significant allocation to U.S. equities, comprising 90.98% of its assets, with minimal exposure to bonds and cash. This asset allocation strategy underscores the fund’s focus on capital appreciation through equity investments, while the lack of bond exposure suggests limited income generation and a higher risk profile.
Risk Metrics and Considerations
Investors should be aware of the risk metrics associated with PRSVX. The fund’s alpha of -0.97% and Sharpe ratio of -0.05 indicate that it has underperformed on a risk-adjusted basis compared to its benchmark. The standard deviation of 5.36% and downside risk of 3.14% further highlight the potential for volatility and losses. Additionally, the fund’s R-squared value of 56.99% suggests that a significant portion of its performance can be attributed to market movements, rather than the fund manager’s stock-picking abilities. These metrics are crucial for investors to consider, especially those with a lower risk tolerance.
Competitive Expense Ratio
One of the standout features of PRSVX is its competitive expense ratio of 0.8%, which is relatively low for a small-cap fund. This cost efficiency can be particularly appealing to investors who are mindful of fees and their impact on net returns. In comparison to similar funds, such as Optimum Small/MidCapGrowth-Inst (OISGX) and Loomis Sayles SmallCap Growth-Inst (LSSIX), PRSVX offers a cost-effective option for those seeking exposure to undervalued small-cap stocks. Lower expenses can enhance overall returns, making this fund an attractive choice for cost-conscious investors.
Comparative Analysis with Peers
When compared to similar funds, PRSVX holds its ground with a strong 1-year return of 36.69%. For instance, Allspring Discovery SmallCap Growth-A (EGWAX) achieved a slightly higher return of 39.28%, but with a higher beta of 1.31, indicating greater volatility. PRSVX’s expense ratio of 0.8% is also competitive, especially when compared to funds like HSBC Radiant US Smaller Companies-I (RESCX), which has a lower expense ratio but also a higher beta. This comparative analysis suggests that PRSVX offers a balanced approach between cost and performance, making it a viable option for investors seeking small-cap exposure.
Investor Suitability and Considerations
PRSVX is particularly suitable for investors who are seeking long-term capital growth and are comfortable with the risks associated with small-cap investments. The fund’s focus on undervalued stocks provides the potential for significant capital appreciation, but it also comes with higher volatility and risk. Investors with a higher risk tolerance and a long-term investment horizon may find this fund appealing. However, those seeking income generation or lower volatility may need to consider other options, given the fund’s limited bond exposure and higher market sensitivity.
Conclusion: A Strategic Choice for Growth-Oriented Investors
In conclusion, TRPrice SmallCap Value-Inv (PRSVX) stands out as a strategic choice for growth-oriented investors looking to capitalize on undervalued small-cap stocks. With a competitive expense ratio and a strong recent performance, the fund offers a compelling opportunity for those willing to embrace the associated risks. Its focus on sectors like financials and real estate aligns with its value-driven strategy, while the fund’s higher beta and volatility metrics underscore the need for a risk-tolerant investor profile. Overall, PRSVX is well-suited for investors seeking to enhance their portfolio with small-cap growth potential.
Similar Securities
GTSAX: Invesco SmallCap Growth-A | High-Potential Small-Cap Investment
GTSAX offers high growth potential with a 41.82% 1-year return, focusing on small-cap equities. Competitive in its category with a 1.17% expense ratio.
PRDSX: TRPrice Integrated US SMCap Grwth Eq-Inv | Small Cap Growth Fund Analysis
PRDSX offers a diversified small-cap growth portfolio with a competitive 0.8% expense ratio and strong 1-year return of 39.46%, outperforming its benchmark.
MASKX: iShares Russell 2000 SmallCap IxFd-Inst | Small-Cap Growth Opportunity
MASKX offers low-cost exposure to small-cap US stocks with a 0.12% expense ratio, outperforming its benchmark with a 40.82% 1-year return.
PSLAX: Putnam SmallCap Value-A | Undervalued Small-Cap Investment
PSLAX focuses on undervalued small-cap US stocks, offering potential for capital appreciation with a 1.18% expense ratio.
JSIVX: Janus Henderson SmallCap Value-L | Undervalued Small-Cap Stock Investment
JSIVX offers small-cap value exposure with a focus on undervalued stocks, a 0.75% expense ratio, and a 33.33% 1-year return.
Futher Reading
https://finance.yahoo.com/quote/PRSVX/”>Yahoo: TRPrice SmallCap Value-Inv
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial, investment, or other professional advice. PeepFinance does not endorse or recommend any specific securities, investments, or strategies. The opinions expressed are solely those of the authors and are not intended to be used as the basis for any investment decisions. All investments carry risks, and readers are encouraged to conduct their own research or consult with a financial professional before making any financial decisions. PeepFinance and its authors are not responsible for any losses or damages arising from the use of this information.